Sandoz says new clinical data support two biosimilars
The trials shows the efficacy and safety of biosimilar adalimumab
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis posts eye drug data amid play for Eylea’s turf
The Basel-based drugmaker hopes this latest analysis lends RTH258 additional muscle when matched head-to-head with Eylea
J&J’s Stelara shows promise against lupus in study
J&J said the results were strong enough to advance Stelara into larger Phase III testing
‘We received an excellent reaction from the European market’
Suresh Pareek, MD, Ideal Cures, in an interaction with Express Pharma, talks about the uniqueness of INSTACOAT 4G, which was…
Risk-based monitoring: Gaining ground
Risk-based monitoring (RBM) adoption is building momentum as pharma companies and CROs are shifting focus and are developing…
Beyond just a filler – application of calcium phosphates in direct compression formulations
Daniel Zakowiecki, Marek Lachmann and Tobias Heß Chemische Fabrik Budenheim, in this article outlines the most important…
Time limit for stroke treatment may be longer in selected patients
The patients, all of whom had an occlusion of the intracranial internal carotid or proximal middle cerebral artery, were treated…
Trial data suggests new typhoid shot could halve infection rate
The vaccine developed by Bharat Biotech could also be used safely in babies
Coating performance evaluation of INSTACOAT 4G using various spray guns
Suresh Pareek, MD, Ideal Cures and Sanjay Negi, DGM Film Coatings, Ideal Cures, give an insight the coating performance of IDEAL…
‘We are able to make many advances in XRPD to address industry needs’
Dr Michael Caves, India Business Development Manager, Malvern Instruments, in an interaction with Express Pharma, talks about the…